NASDAQ:IBB - iShares Nasdaq Biotechnology ETF Stock Price, Forecast & News

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF announced a quarterly dividend on Monday, December 16th. Shareholders of record on Tuesday, December 17th will be paid a dividend of $0.0578 per share on Friday, December 20th. This represents a $0.23 annualized dividend and a yield of 0.19%. The ex-dividend date is Monday, December 16th. View iShares Nasdaq Biotechnology ETF's Dividend History.

iShares Nasdaq Biotechnology ETF's stock split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

News stories about IBB stock have trended positive on Monday, according to InfoTrie. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned news stories about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for iShares Nasdaq Biotechnology ETF.

Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Gabelli Equity Trust (GAB), Tri-Continental (TY), Hercules Capital (HTGC), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF), Tortoise Energy Infrastructure (TYG), PIMCO High Income Fund (PHK) and General American Investors (GAM).

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Bank of America (BAC), Walt Disney (DIS), Tesla (TSLA), Gilead Sciences (GILD), Cisco Systems (CSCO), First Solar (FSLR) and Alphabet (GOOG).

iShares Nasdaq Biotechnology ETF's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Neville Rodie & Shaw Inc. (0.10%), Calamos Advisors LLC (0.10%), Appleton Partners Inc. MA (0.08%), Alpha Cubed Investments LLC (0.08%), Steward Partners Investment Advisory LLC (0.07%) and McGuire Investment Group LLC (0.06%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Diligent Investors LLC, Kistler Tiffany Companies LLC, Winfield Associates Inc., Neville Rodie & Shaw Inc., Surevest Inc., Appleton Partners Inc. MA and Aua Capital Management LLC.

IBB stock was purchased by a variety of institutional investors in the last quarter, including Mirador Capital Partners LP, Calamos Advisors LLC, Tocqueville Asset Management L.P., Alpha Cubed Investments LLC, Hamilton Wealth LLC, Centric Wealth Management, Bangor Savings Bank and Clarus Wealth Advisors.

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $121.89.

iShares Nasdaq Biotechnology ETF has a market capitalization of $7.64 billion. View Additional Information About iShares Nasdaq Biotechnology ETF.